Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-12-02 4:31 pm Purchase | 2020-11-22 | 13G | Iterum Therapeutics plc ITRM | RA Capital Management, L.P. | 666,667 18.900% | 666,667 (New Position) | Filing History |
| 2020-10-09 4:29 pm Purchase | 2020-09-30 | 13G | Cardiff Oncology, Inc. CRDF | RA Capital Management, L.P. | 3,290,000 10.900% | 3,290,000 (New Position) | Filing History |
| 2020-10-07 5:00 pm Sale | 2020-10-05 | 13D | EIDOS THERAPEUTICS INC EIDX | RA Capital Management, L.P. | 1,798,339 4.700% | -364,332 (-16.85%) | Filing History |
| 2020-09-21 5:24 pm Purchase | 2009-02-28 | 13D | 89bio, Inc. ETNB | RA Capital Management, L.P. | 4,736,214 23.800% | 1,300,000 (+37.83%) | Filing History |
| 2020-09-10 4:29 pm Purchase | 2020-03-31 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 5,818,862 10.900% | 1,633,520 (+39.03%) | Filing History |
| 2020-08-05 4:30 pm Purchase | 2009-02-28 | 13D | iTeos Therapeutics, Inc. ITOS | RA Capital Management, L.P. | 4,417,259 13.200% | 4,417,259 (New Position) | Filing History |
| 2020-07-24 4:34 pm Purchase | 2009-02-28 | 13D | Nkarta, Inc. NKTX | RA Capital Management, L.P. | 5,605,129 17.200% | 5,605,129 (New Position) | Filing History |
| 2020-07-10 4:33 pm Purchase | 2020-06-30 | 13G | Vaxcyte, Inc. PCVX | RA Capital Management, L.P. | 5,489,181 10.800% | 5,489,181 (New Position) | Filing History |
| 2020-07-10 4:30 pm Purchase | 2009-02-28 | 13D | 89bio, Inc. ETNB | RA Capital Management, L.P. | 3,436,214 20.400% | 275,000 (+8.70%) | Filing History |
| 2020-07-10 4:24 pm Sale | 2020-03-03 | 13G | Verastem, Inc. VSTM | RA Capital Management, L.P. | 760,771 5.600% | -789,617 (-50.93%) | Filing History |
| 2020-06-25 5:02 pm Purchase | 2009-02-28 | 13D | Forma Therapeutics Holdings, Inc. FMTX | RA Capital Management, L.P. | 9,011,651 23.400% | 9,011,651 (New Position) | Filing History |
| 2020-06-10 4:15 pm Purchase | 2020-05-31 | 13G | TG Therapeutics, Inc. TGTX | RA Capital Management, L.P. | 12,788,457 10.800% | 2,908,134 (+29.43%) | Filing History |